Company Filing History:
2 out of 7 
2 out of 15 Years Active: 2017-2020
Title: Peter Van Veelen: Innovator in Molecular Biology
Introduction
Peter Van Veelen is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of molecular biology, particularly in the diagnosis of rheumatoid arthritis. With a total of two patents to his name, Van Veelen's work has the potential to impact the medical community significantly.
Latest Patents
Peter Van Veelen's latest patents focus on compositions and methods for the diagnosis of rheumatoid arthritis. These patents specifically relate to methods for detecting anti-carbamylated protein (anti-CarP) antibodies in the serum of rheumatoid arthritis patients. His innovative approaches aim to enhance the accuracy and efficiency of diagnosing this chronic condition.
Career Highlights
Throughout his career, Van Veelen has worked with reputable organizations such as Inova Diagnostics, Inc. and Leiden University Medical Center. His experience in these institutions has allowed him to develop and refine his expertise in molecular biology and diagnostics.
Collaborations
Peter Van Veelen has collaborated with esteemed colleagues, including Michael Mahler and Leendert Adrianus Trouw. These partnerships have contributed to the advancement of research and innovation in his field.
Conclusion
Peter Van Veelen stands out as an influential inventor in molecular biology, with a focus on improving the diagnosis of rheumatoid arthritis. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.